Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet…
Latest
-
-
Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical and corporate updates…
-
Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on its ISLA-101…
-
Investing
Spodumene Pegmatite Discovery at Esperança Project in Brazil Yields LIBS Results up to 4.04% Li2O
by adminLightning Minerals (L1M or the Company) is delighted to announce the discovery of spodumene within a lithium bearing pegmatite at the Company’s…
-
Provaris Energy Ltd (ASX.PV1, Provaris, the Company) is pleased to present the notice of initial substantial holder. Click here for the full…
-
Investing
Gunnison Releases PEA for Arizona Copper Project, Plans for Open-pit, Heap-leach Operation
by adminGunnison Copper (TSX:GCU,OTCQB:EXMGF) is shifting its development strategy for the Gunnison copper project in Arizona, US, laying out plans for a conventional…
-
Investing
Group Eleven Resources Corp. to Attend the 50th Annual New Orleans Investment Conference
by adminGroup Eleven Resources Corp. (TSXV: ZNG) (OTC Pink: GRLVF) is pleased to announce its participation at the upcoming New Orleans Investment Conference…
-
HIGHLIGHTS 27m @ 2.7 grams per tonne (‘g/t’) gold equivalent (AuEq.), including 12m @ 3.9 g/t AuEq. from 435m downhole in OEDD-98.…